Publication: Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.
dc.contributor.author | Turk, HM | |
dc.contributor.author | Kocyigit, A | |
dc.contributor.author | Aliyev, A | |
dc.contributor.author | Celik, RS | |
dc.contributor.author | Seker, MESUT | |
dc.contributor.author | Coban, E | |
dc.contributor.author | Demir, T | |
dc.contributor.author | Baydas, T | |
dc.contributor.institutionauthor | TÜRK, HACI MEHMET | |
dc.contributor.institutionauthor | ŞEKER, MESUT | |
dc.contributor.institutionauthor | KOÇYİĞİT, ABDÜRRAHİM | |
dc.date.accessioned | 2020-02-02T20:59:35Z | |
dc.date.available | 2020-02-02T20:59:35Z | |
dc.date.issued | 2019-07-29T00:00:00Z | |
dc.description.abstract | Objective: M30 and M65 levels reflect tumor cell activity in patients with epithelial cancer. Cytokeratin 18 is one of the cell skeletal elements. M30 is a apoptotic marker of cytokeratin 18. M65 levels are both an apoptosis and a necrosis marker. The aim of our study was to determine the predictive value of M30 and M65 levels in neoadjuvant treatment of breast cancer. | |
dc.identifier.citation | Turk H., Aliyev A., Celik R., Seker M., Coban E., Demir T., Baydas T., Kocyigit A., -Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.-, Current problems in cancer, ss.100497, 2019 | |
dc.identifier.doi | 10.1016/j.currproblcancer.2019.06.009 | |
dc.identifier.pubmed | 31371034 | |
dc.identifier.scopus | 85069844749 | |
dc.identifier.uri | https://openaccess.bezmialem.edu.tr/handle/20.500.12645/14046 | |
dc.title | Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. | |
dc.type | Article | |
dspace.entity.type | Publication | |
local.avesis.id | 6ecbee3c-6a16-4d27-9eac-f262e32e5b08 | |
local.indexed.at | PubMed | |
local.indexed.at | Scopus | |
local.publication.goal | 03 - Sağlık ve Kaliteli Yaşam | |
local.publication.isinternational | 1 | |
relation.isAuthorOfPublication | 1b3a1540-7e57-405d-8a9d-f926d17dcc29 | |
relation.isAuthorOfPublication | 8a03684e-e421-4a9f-9069-168fc121a5d4 | |
relation.isAuthorOfPublication | 75babbd2-f46b-4121-aa00-54d883a6f907 | |
relation.isAuthorOfPublication.latestForDiscovery | 1b3a1540-7e57-405d-8a9d-f926d17dcc29 | |
relation.isGoalOfPublication | 9c198c48-b603-4e2f-8366-04edcfc1224c | |
relation.isGoalOfPublication.latestForDiscovery | 9c198c48-b603-4e2f-8366-04edcfc1224c |